Redhill Biopharma (RDHL) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Redhill Biopharma's actual EPS was -$200.00, missing the estimate of -$30.60 per share, resulting in a -553.59% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
